Clinical Colorectal Cancer
Latest Publications

TOTAL DOCUMENTS

1398

(FIVE YEARS 204)

H-INDEX

(FIVE YEARS 4)

Published By Elsevier

1938-0674, 1533-0028

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Tumor-infiltrating PD-1+ immune cell density is associated with response to neoadjuvant chemoradiotherapy in rectal cancer

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2022.01.004 ◽

2022 ◽

Author(s):

Yusuke Kitagawa ◽

Takashi Akiyoshi ◽

Noriko Yamamoto ◽

Toshiki Mukai ◽

Yukiharu Hiyoshi ◽

...

Keyword(s):

Rectal Cancer ◽

Cell Density ◽

Immune Cell ◽

Neoadjuvant Chemoradiotherapy

Download Full-text

Intraoperative radiation after pelvic short course radiation-based total neoadjuvant therapy for patients with rectal adenocarcinoma at high risk for local recurrence.

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2022.01.002 ◽

2022 ◽

Author(s):

Zooha Khan ◽

Michael K. Rooney ◽

Prajnan Das ◽

Ethan B. Ludmir ◽

Eugene J. Koay ◽

...

Keyword(s):

High Risk ◽

Local Recurrence ◽

Neoadjuvant Therapy ◽

Rectal Adenocarcinoma ◽

Intraoperative Radiation ◽

Short Course ◽

Total Neoadjuvant Therapy

Download Full-text

Restoring immune mediated disease control by ipilimumab re-exposition in a heavily pre-treated patient with MSI-H mCRC

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2022.01.003 ◽

2022 ◽

Author(s):

Frank Jordan ◽

Martin Trepel ◽

Rainer Claus

Keyword(s):

Disease Control ◽

Treated Patient ◽

Immune Mediated

Download Full-text

Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2022.01.005 ◽

2022 ◽

Author(s):

Davide Ciardiello ◽

Vincenzo Famiglietti ◽

Stefania Napolitano ◽

Lucia Esposito ◽

Filippo Pietrantonio ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Neutrophil To Lymphocyte Ratio ◽

Wild Type ◽

Lymphocyte Ratio ◽

Colorectal Cancer Patients

Download Full-text

Rechallenge with BRAF and anti-EGFR inhibitors in patients with metastatic colorectal cancer harboring BRAF mutation who progressed on cetuximab and encorafenib with or without binimetinib: a case series

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2021.12.001 ◽

2021 ◽

Author(s):

Ji Jingran ◽

Wang Chongkai ◽

Fakih Marwan

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Braf Mutation ◽

Case Series ◽

Egfr Inhibitors

Download Full-text

Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2021.11.006 ◽

2021 ◽

Author(s):

Irene S. Yu ◽

Zamzam Al-Hashami ◽

Parv Chapani ◽

Caroline Speers ◽

Janine M. Davies ◽

...

Keyword(s):

Small Bowel ◽

Patient Outcomes ◽

Tumor Location

Download Full-text

TRIFLURIDINE/TIPIRACIL IN COMBINATION WITH BEVACIZUMAB IN FIRST-LINE FOR METASTATIC COLORECTAL CANCER: A WAY FORWARD. A POINT OF VIEW BASED ON COST-EFFECTIVENESS

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2021.11.012 ◽

2021 ◽

Author(s):

Jacopo Giuliani

Keyword(s):

Colorectal Cancer ◽

Cost Effectiveness ◽

Metastatic Colorectal Cancer ◽

Point Of View ◽

First Line

Download Full-text

Editorial Board

Clinical Colorectal Cancer ◽

10.1016/s1533-0028(21)00115-8 ◽

2021 ◽

Vol 20 (4) ◽

pp. A1

Download Full-text

Total neoadjuvant therapy for high risk rectal cancer in Western and Asian populations – current evidence and clinical applications

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2021.12.004 ◽

2021 ◽

Author(s):

David Johnson ◽

Leung Li ◽

Kin-Chung Lee ◽

KO Lam ◽

KH Wong ◽

...

Keyword(s):

Rectal Cancer ◽

High Risk ◽

Neoadjuvant Therapy ◽

Clinical Applications ◽

Current Evidence ◽

Asian Populations ◽

Total Neoadjuvant Therapy

Download Full-text

Clinical Colorectal Cancer ◽

10.1016/s1533-0028(21)00116-x ◽

2021 ◽

Vol 20 (4) ◽

pp. A3-A6

Download Full-text

Clinical Colorectal Cancer
Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier

Tumor-infiltrating PD-1+ immune cell density is associated with response to neoadjuvant chemoradiotherapy in rectal cancer

Intraoperative radiation after pelvic short course radiation-based total neoadjuvant therapy for patients with rectal adenocarcinoma at high risk for local recurrence.

Restoring immune mediated disease control by ipilimumab re-exposition in a heavily pre-treated patient with MSI-H mCRC

Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival

Rechallenge with BRAF and anti-EGFR inhibitors in patients with metastatic colorectal cancer harboring BRAF mutation who progressed on cetuximab and encorafenib with or without binimetinib: a case series

Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers

TRIFLURIDINE/TIPIRACIL IN COMBINATION WITH BEVACIZUMAB IN FIRST-LINE FOR METASTATIC COLORECTAL CANCER: A WAY FORWARD. A POINT OF VIEW BASED ON COST-EFFECTIVENESS

Editorial Board

Total neoadjuvant therapy for high risk rectal cancer in Western and Asian populations – current evidence and clinical applications

Table of contents

Export Citation Format

Clinical Colorectal CancerLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier

Tumor-infiltrating PD-1+ immune cell density is associated with response to neoadjuvant chemoradiotherapy in rectal cancer

Intraoperative radiation after pelvic short course radiation-based total neoadjuvant therapy for patients with rectal adenocarcinoma at high risk for local recurrence.

Restoring immune mediated disease control by ipilimumab re-exposition in a heavily pre-treated patient with MSI-H mCRC

Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival

Rechallenge with BRAF and anti-EGFR inhibitors in patients with metastatic colorectal cancer harboring BRAF mutation who progressed on cetuximab and encorafenib with or without binimetinib: a case series

Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers

TRIFLURIDINE/TIPIRACIL IN COMBINATION WITH BEVACIZUMAB IN FIRST-LINE FOR METASTATIC COLORECTAL CANCER: A WAY FORWARD. A POINT OF VIEW BASED ON COST-EFFECTIVENESS

Editorial Board

Total neoadjuvant therapy for high risk rectal cancer in Western and Asian populations – current evidence and clinical applications

Table of contents

Clinical Colorectal Cancer
Latest Publications